CEBPA are independent good prognostic factors in pediatric acute myeloid leukemia-Reference-Cited by-同舟云学术

CEBPA are independent good prognostic factors in pediatric acute myeloid leukemia

Published:2021-11-27 Issue: Volume: Page:
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Liao Xiong‐yu¹²,Fang Jian‐pei¹²,Zhou Dun‐hua¹²,Qiu Kun‐yin¹²^ORCID

Affiliation:

1. Children's Medical Center Sun Yat‐sen Memorial Hospital, Sun Yat‐sen University Guangzhou China

2. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Sun Yat‐Sen Memorial Hospital, Sun Yat‐Sen University Guangzhou China

Funder

Guangzhou Science and Technology Program key projects

Guangdong Science and Technology Department

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2951

Reference39 articles.

1. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia;Schlenk RF;N Engl J Med,2008

2. The incidence and clinical significance of nucleophosmin mutations in childhood AML;Brown P;Blood,2007

3. Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype;Cazzaniga G;Blood,2005

4. Nucleophosmin mutations in de novo acute myeloid leukemia: the age‐dependent incidences and the stability during disease evolution;Chou WC;Cancer Res,2006

5. Different types of NPM1 mutations in children and adults: evidence for an effect of patient age on the prevalence of the TCTG‐tandem duplication in NPM1‐exon 12;Thiede C;Leukemia,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutations in the bZip region of the CEBPA gene: A novel prognostic factor in patients with acute myeloid leukemia;International Journal of Laboratory Hematology;2023-08-24

2. Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectives;Seminars in Cancer Biology;2023-07

3. Outcome and prognostic factors of CBF pediatric AML patients with t(8;21) differ from patients with inv(16);BMC Cancer;2023-05-25

4. mRNA-lncRNA gene expression signature for predicting pediatric AML relapse;Current Research in Translational Medicine;2023-04

5. La leucémie aiguë myéloïde pédiatrique, une entité clinico-biologique ?;Revue Francophone des Laboratoires;2023-04